Loading page…
Healthcare
AstraZeneca PLC records an AlphaScore of 63/100 in the Healthcare sector as of the October 11, 2026 snapshot. Key figures feature a strong gross margin of 81.9% and a solid return on equity (ROE) of 21.96%. A primary strength is its high gross margin, demonstrating effective intellectual property monetization and drug pricing power. A potential risk is its debt-to-equity ratio of 0.64, indicating moderate financial liabilities. Evidence is limited strictly to the supplied data.
Written 11/10/2026, 00:23:45 UTC · Snapshot 11/10/2026